Literature DB >> 6796901

Peripheral neurofibromatosis and peroneal muscular atrophy.

E P Bosch, M J Murphy, P A Cancilla.   

Abstract

We studied four patients with peripheral neurofibromatosis and a neuropathy that had the clinical characteristics of peroneal muscular atrophy. Nerve conduction velocities were slowed by less than 40% of normal, and electromyography demonstrated denervation. Sural nerve biopsies from two patients, which were macroscopically free of nerve sheath tumors, were studied by recording the compound action potentials in vitro and by morphometry. These studies demonstrated a chronic axonal neuropathy with reactive Schwann cell changes. Peroneal muscular atrophy in association with neurofibromatosis may be due to progressive neuronal degeneration and may represent another, uncommon manifestation of peripheral neurofibromatosis.

Entities:  

Mesh:

Year:  1981        PMID: 6796901     DOI: 10.1212/wnl.31.11.1408

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1.

Authors:  Aubin Moutal; Erik T Dustrude; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2016-05-11       Impact factor: 5.590

Review 2.  Charcot-Marie-Tooth syndrome and neurofibromatosis type 1 with multiple neurofibromas of the entire spinal nerve roots.

Authors:  David O Onu; Andrew W Hunn; Jens Peters-Willke
Journal:  BMJ Case Rep       Date:  2013-07-13

3.  Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.

Authors:  P Bäumer; V F Mautner; T Bäumer; M U Schuhmann; M Tatagiba; S Heiland; T Kaestel; M Bendszus; M Pham
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

4.  A case of neurofibromatosis 2 presenting with a mononeuritis multiplex.

Authors:  T J Kilpatrick; R J Hjorth; M F Gonzales
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

5.  A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1B.

Authors:  Eric Lancaster; Lauren B Elman; Steven S Scherer
Journal:  Muscle Nerve       Date:  2010-04       Impact factor: 3.217

Review 6.  A neuronal function of the tumor suppressor protein merlin.

Authors:  Alexander Schulz; Ansgar Zoch; Helen Morrison
Journal:  Acta Neuropathol Commun       Date:  2014-07-12       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.